Publications
- Major changes in the treatment of small cell lung cancer2023 | Third Faculty of Medicine
- Worse Prognosis in the Symptomatic Patients With Lung Cancer - Czech Multicentric Study2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Two years longer and peaceful life thanks to alectinib2022 | Third Faculty of Medicine, Central Library of Charles University
- Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment2021 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Effect of clinical parameters on second- and third-line erlotinib treatment of EGFR wild type patients with advanced NSCLC2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Second Faculty of Medicine
- Treatment of malignant pleural mesothelioma in the Czech Republic2019 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Optimal procedure in treatments of advanced ALK-positive and ROS1-positive non-small cell lung cancers2019 | Third Faculty of Medicine
- Osimertinib and its use in the treatment of non-small cell lung carcinoma in the Czech Republic2018 | Third Faculty of Medicine
- Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer2023 | Faculty of Medicine in Pilsen, Third Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové
Loading network view...